• 

  Brand Guidelines, Branding

  Henlius Brand Guidelines: Fosun’s 2010 Shanghai Biologics Unit, Zercepac & a Failed Buyout

  November 9, 2026

• 

  Brand Guidelines, Branding

  Coherus Brand Guidelines: A 2010 Biosimilar Start, Three Sales & a 2025 Oncology Rename

  November 9, 2026

• 

  Brand Guidelines, Branding

  Alvotech Brand Guidelines: Reykjavík 2013, a 2022 Nasdaq Debut & a Biosimilars-Only Plan

  November 9, 2026

• 

  Brand Guidelines, Branding

  Formycon Brand Guidelines: A Boehringer Mannheim Offshoot Behind FYB201, FYB202 & FYB203

  November 9, 2026

• 

  Brand Guidelines, Branding

  Biocon Biologics Brand Guidelines: A 1978 Enzyme Firm, the Viatris Deal & a 2026 Return

  November 9, 2026

• 

  Brand Guidelines, Branding

  Samsung Bioepis Brand Guidelines: A 2012 Biogen Venture, Benepali & the 2025 Spin-Off

  November 9, 2026

• 

  Brand Guidelines, Branding

  Celltrion Brand Guidelines: Incheon 2002, Remsima & the 2023 Celltrion Healthcare Merger

  November 9, 2026

• 

  Brand Guidelines, Branding

  Hesai Brand Guidelines: The Shanghai Lidar Maker Listed in New York and Hong Kong

  November 9, 2026

• 

  Brand Guidelines, Branding

  Ouster Brand Guidelines: The San Francisco Lidar Maker That Merged With Velodyne

  November 9, 2026

• 

  Brand Guidelines, Branding

  Wayve Brand Guidelines: A Cambridge Start, an End-to-End AI Driver & Robotaxi Rides in London

  November 9, 2026

• 

  Brand Guidelines, Branding

  WeRide Brand Guidelines: Tony Han’s 2017 Start, the GXR Robotaxi & Two Stock Listings

  November 9, 2026

• 

  Brand Guidelines, Branding

  Pony.ai Brand Guidelines: Robotaxis From Silicon Valley & Guangzhou, Listed Twice

  November 9, 2026